Role of vascular density and normalization in response to neoadjuvant bevacizumab and chemotherapy in breast cancer patients is a research paper published in Proceedings of the National Academy of Sciences (2015). On theSindex it has a DataRank of 0.833. It has been cited 257 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.833
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Genentech
Grant: Gen24357
HHS | NIH | National Cancer Institute
Grant: 2P50 CA089393-08S2
U.S. Department of Defense
Grant: W81XWH-10-1-0016
Susan G. Komen for the Cure
Grant: PDF14301739
Associazione Italiana per la Ricerca sul Cancro
Grant: 13604
HHS | NIH | National Cancer Institute
Grant: R01CA098706
NCI NIH HHS
Grant: P01 CA080124
NCI NIH HHS
Grant: P50 CA089393
FWCI
9.91
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Inhibition of stromal biglycan promotes normalization of the tumor microenvironment and enhances chemotherapeutic efficacy
Additional file 1 of Inhibition of stromal biglycan promotes normalization of the tumor microenvironment and enhances chemotherapeutic efficacy
Additional file 2 of Inhibition of stromal biglycan promotes normalization of the tumor microenvironment and enhances chemotherapeutic efficacy
Additional file 2 of Inhibition of stromal biglycan promotes normalization of the tumor microenvironment and enhances chemotherapeutic efficacy